Smartwatch Detection of Atrial Fibrillation After Surgery

Diagnosis of Atrial Fibrillation in Postoperative Thoracic Surgery Using a Smartwatch

Recruiting N/A Interventional Study
Postoperative Atrial Fibrillation Thoracic Surgery Smartwatches Rhythm Monitoring Cardiovascular Prognosis Asymptomatic Atrial Fibrillation Randomized Trial
No Placebo Group Every participant receives an active treatment — no one gets a placebo.
Ready to participate?

Review the details below, then apply to join this clinical trial.

At a Glance
Age
18 and older
Sex
Any
Study type
Interventional
Purpose
Other
Participants needed
302 (estimated)
Sponsor
Centre Hospitalier Universitaire, Amiens · Other
Who this trial is looking for

This trial is looking for adults who recently had major thoracic surgery. Participants will use a smartwatch to help detect a heart condition called postoperative atrial fibrillation.

Are You a Good Fit for This Trial?

You may be able to join if

  • I am over 18 years old.
  • I had major thoracic surgery within the last 48 hours.
  • I am scheduled for a pneumonectomy or lobectomy.
  • I am staying in a standard surgical unit after my surgery.
  • I can use a smartwatch to take a heart reading.
  • I have social security coverage.
  • I provide signed consent to participate.

You may not be able to join if

  • I have a history of atrial fibrillation.
  • I need constant monitoring for heart issues.
  • I depend on a pacemaker.
  • I am taking part in another study affecting atrial fibrillation.
  • I had other chest surgeries.
  • I had surgery more than 48 hours ago.
  • I am pregnant.
  • I am under legal guardianship.

Summarized in plain language from this trial's official eligibility criteria. The full criteria are further down this page — only the research team can confirm whether you qualify.

Think this trial could be right for you?

Answer a few quick questions to see if you may meet the eligibility requirements.

Check Your Eligibility
About This Trial
Postoperative atrial fibrillation (POAF) occurs in approximately 20% of patients following thoracic surgery. Early diagnosis is essential to prevent complications such as heart failure, stroke, myocardial infarction, and increased mortality. Smartwatches equipped with single-lead ECG capabilities and algorithms to detect asymptomatic atrial fibrillation (AF) offer a potential solution. This study …
Trial Locations
Loading…

Loading trial locations…

Eligibility Criteria
Inclusion Criteria: * Adults (\>18 years old). * Patients undergoing major thoracic surgery with one-lung ventilation within the past 48 hours. * Scheduled pneumonectomy or lobectomy. * Admission to a conventional surgical unit postoperatively. * Ability to perform single-lead ECG using a smartwatc…
Contacts

Pierre Huette, MD

33322088371

Huette.pierre@chu-amiens.fr

CONTACT